查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1467773

2024-2032 年按组件、治疗领域、最终用户和地区分類的真实世界证据解决方案市场报告

Real-World Evidence Solutions Market Report by Component, Therapeutic Area, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

2023 年，IMARC Group现实世界证据解决方案市场规模达到 18 亿美元。

真实世界证据（RWE）是指透过真实世界资料（RWD）了解医疗产品的使用以及潜在益处或风险的临床证据。它可以透过不同的研究设计或分析来产生，包括随机试验、大型简单试验、实用试验和观察性研究。它提供了对患者群体真实治疗模式的深入了解，包括剂量、依从性、依从性、标籤外使用以及疗效和安全性之间的平衡。由于它还可以帮助研究人员发现可能的患者并制定正确的临床试验纳入标准，从而帮助他们设计更好的预试验研究，因此全球对 RWE 解决方案的需求不断增加。

真实世界证据解决方案市场趋势：

对 RWE 解决方案的需求不断增长，以获取有关新产品安全性和功效的准确、清晰的信息，这是推动市场发展的关键因素之一。此外，对这些解决方案的需求不断增加，以检测复杂和共病患者使用时的不同反应、产品亚群效应和产品价值。这与蓬勃发展的医疗保健行业一起推动了市场的成长。此外，RWE 越来越多地利用先进分析和技术解决方案进行临床开发、商业化、加速创新和加速改善医疗保健结果，这对市场产生了积极影响。除此之外，多个国家的政府也采取了各种措施来促进 RWE 解决方案的使用，这些解决方案提供了药物和疫苗的功效。再加上从数量型护理转向基于价值的护理，为行业投资者提供了利润丰厚的成长机会。除此之外，数位化和以患者为中心的虚拟护理的日益普及正在刺激对 RWE 解决方案的需求。此外，全球癌症、肥胖和糖尿病等慢性疾病的盛行率也在增加。与此一致的是，药物开发的不断拖延以及随后开发成本的增加正在支持市场的成长。

本报告回答的关键问题

  • 2023 年全球现实世界证据解决方案市场规模有多大？
  • 2024-2032 年全球现实世界证据解决方案市场的预期成长率为何？
  • 推动全球现实世界证据解决方案市场的关键因素是什么？
  • COVID-19 对全球现实世界证据解决方案市场有何影响？
  • 基于组件的全球现实世界证据解决方案市场的细分是什么？
  • 基于治疗领域的全球现实世界证据解决方案市场的细分是什么？
  • 基于最终用户的全球现实世界证据解决方案市场的细分是什么？
  • 全球现实世界证据解决方案市场的关键区域有哪些？
  • 谁是全球现实证据解决方案市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球真实世界证据解决方案市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按组成部分

  • 临床设定数据
    • 市场走向
    • 市场预测
  • 索赔数据
    • 市场走向
    • 市场预测
  • 患者驱动的数据
    • 市场走向
    • 市场预测
  • 药房数据
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依治疗领域

  • 肿瘤学
    • 市场走向
    • 市场预测
  • 免疫学
    • 市场走向
    • 市场预测
  • 神经病学
    • 市场走向
    • 市场预测
  • 心血管疾病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依最终用户

  • 製药及医疗器材公司
    • 市场走向
    • 市场预测
  • 医疗保健支付者
    • 市场走向
    • 市场预测
  • 医疗保健机构
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Aetion Inc.
    • Clinigen Limited
    • Flatiron Health Inc. (Roche Holding AG)
    • ICON plc
    • International Business Machines Corporation
    • IQVIA
    • Optum Inc. (UnitedHealth Group Incorporated)
    • Oracle Corporation
    • Parexel International Corporation
    • PPD Inc. (Thermo Fisher Scientific Inc.)
    • Sas Institute Inc.
    • Syneos Health
Product Code: SR112024A6149

The global real-world evidence solutions market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.6% during 2024-2032.

Real-world evidence (RWE) refers to clinical evidence about the use and potential benefits or risks of medical products via real-world data (RWD). It can be produced via different study designs or analyses, including randomized trials, big simple trials, pragmatic trials, and observational studies. It provides insight into real-world treatment patterns in patient groups, including dosing, compliance, adherence, off-label use, and the balance between efficacy and safety. As it can also assist researchers in discovering possible patients and developing correct inclusion criteria for clinical trials, which can help them design better pre-trial studies, there is a rise in the demand for RWE solutions around the world.

Real-World Evidence Solutions Market Trends:

The growing demand for RWE solutions to get precise and clear information about the safety and efficacy of new products represents one of the key factors driving the market. Moreover, there is a rise in the demand for these solutions to detect varied reactions, product subpopulation effects, and product value when utilized by complex and comorbid patients. This, along with the burgeoning healthcare industry, is propelling the growth of the market. Additionally, the growing utilization of advanced analytics and technological solutions in RWE for clinical development, commercialization, speed innovation, and accelerating improvements in healthcare outcomes is positively influencing the market. Besides this, there are various initiatives undertaken by governments of several countries to promote the use of RWE solutions, which provide the efficacy of drugs and vaccines. This, coupled with a shift from volume to value-based care, is offering lucrative growth opportunities to industry investors. Apart from this, the growing adoption of digitalization and patient-centered virtual care is catalyzing the demand for RWE solutions. Furthermore, there is an increase in the prevalence of chronic diseases, such as cancer, obesity, and diabetes, across the globe. In line with this, the rising delays in drug development and the subsequent increase in development costs are bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global real-world evidence solutions market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on component, therapeutic area and end user.

Breakup by Component:

Clinical Settings Data

Claims Data

Patient-Powered Data

Pharmacy Data

Others

Breakup by Therapeutic Area:

Oncology

Immunology

Neurology

Cardiovascular Disease

Others

Breakup by End User:

Pharmaceutical and Medical Device Companies

Healthcare Payers

Healthcare Providers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aetion Inc., Clinigen Limited, Flatiron Health Inc. (Roche Holding AG), ICON plc, International Business Machines Corporation, IQVIA, Optum Inc. (UnitedHealth Group Incorporated), Oracle Corporation, Parexel International Corporation, PPD Inc. (Thermo Fisher Scientific Inc.), Sas Institute Inc. and Syneos Health.

Key Questions Answered in This Report

  • 1. What was the size of the global real-world evidence solutions market in 2023?
  • 2. What is the expected growth rate of the global real-world evidence solutions market during 2024-2032?
  • 3. What are the key factors driving the global real-world evidence solutions market?
  • 4. What has been the impact of COVID-19 on the global real-world evidence solutions market?
  • 5. What is the breakup of the global real-world evidence solutions market based on the component?
  • 6. What is the breakup of the global real-world evidence solutions market based on the therapeutic area?
  • 7. What is the breakup of the global real-world evidence solutions market based on the end user?
  • 8. What are the key regions in the global real-world evidence solutions market?
  • 9. Who are the key players/companies in the global real-world evidence solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Real-World Evidence Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Clinical Settings Data
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Claims Data
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Patient-Powered Data
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Pharmacy Data
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Therapeutic Area

  • 7.1 Oncology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Immunology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Medical Device Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Healthcare Payers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Healthcare Providers
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Aetion Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Clinigen Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Flatiron Health Inc. (Roche Holding AG)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 ICON plc
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 International Business Machines Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 IQVIA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Optum Inc. (UnitedHealth Group Incorporated)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Oracle Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Parexel International Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 PPD Inc. (Thermo Fisher Scientific Inc.)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Sas Institute Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 SWOT Analysis
    • 14.3.12 Syneos Health
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Real-World Evidence Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Real-World Evidence Solutions Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Real-World Evidence Solutions Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Real-World Evidence Solutions Market: Breakup by Component (in %), 2023
  • Figure 5: Global: Real-World Evidence Solutions Market: Breakup by Therapeutic Area (in %), 2023
  • Figure 6: Global: Real-World Evidence Solutions Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Real-World Evidence Solutions Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Real-World Evidence Solutions (Clinical Settings Data) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Real-World Evidence Solutions (Clinical Settings Data) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Real-World Evidence Solutions (Claims Data) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Real-World Evidence Solutions (Claims Data) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Real-World Evidence Solutions (Patient-Powered Data) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Real-World Evidence Solutions (Patient-Powered Data) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Real-World Evidence Solutions (Pharmacy Data) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Real-World Evidence Solutions (Pharmacy Data) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Real-World Evidence Solutions (Other Components) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Real-World Evidence Solutions (Other Components) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Real-World Evidence Solutions (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Real-World Evidence Solutions (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Real-World Evidence Solutions (Immunology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Real-World Evidence Solutions (Immunology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Real-World Evidence Solutions (Neurology) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Real-World Evidence Solutions (Neurology) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Real-World Evidence Solutions (Cardiovascular Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Real-World Evidence Solutions (Other Therapeutic Areas) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Real-World Evidence Solutions (Pharmaceutical and Medical Device Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Real-World Evidence Solutions (Healthcare Payers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Real-World Evidence Solutions (Healthcare Payers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Real-World Evidence Solutions (Healthcare Providers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Real-World Evidence Solutions (Healthcare Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Real-World Evidence Solutions (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Real-World Evidence Solutions (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Real-World Evidence Solutions Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Real-World Evidence Solutions Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: Real-World Evidence Solutions Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Real-World Evidence Solutions Industry: SWOT Analysis
  • Figure 86: Global: Real-World Evidence Solutions Industry: Value Chain Analysis
  • Figure 87: Global: Real-World Evidence Solutions Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Real-World Evidence Solutions Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Real-World Evidence Solutions Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: Real-World Evidence Solutions Market Forecast: Breakup by Therapeutic Area (in Million US$), 2024-2032
  • Table 4: Global: Real-World Evidence Solutions Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Real-World Evidence Solutions Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Real-World Evidence Solutions Market: Competitive Structure
  • Table 7: Global: Real-World Evidence Solutions Market: Key Players